文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血患者出院后短期结局变化:一项多中心前瞻性观察研究

Changes in Short-Term Outcomes After Discharge in Patients with Aneurysmal Subarachnoid Hemorrhage: A Multicenter, Prospective, Observational Study.
PubMed 文献 · World Neurosurg · 2022-06-08

本研究基于mWFNS量表研究的前瞻性数据回顾性分析动脉瘤性蛛网膜下腔出血患者出院至发病后3个月改良Rankin量表(mRS)评分变化,发现28.3%患者改善、2.5%下降;入院WFNS和mWFNS Ⅱ-V级与3个月mRS改善显著相关,高龄和WFNS Ⅲ级与mRS下降显著相关。

要点

  • 出院至发病后3个月mRS评分改善者占28.3%,下降者占2.5%。
  • 入院WFNS和mWFNS Ⅱ-V级与3个月mRS评分改善显著相关。
  • 年龄65-74岁和≥75岁及WFNS Ⅲ级与3个月mRS评分下降显著相关。

核心结论

  • 出院后结局评估的最佳时机可能为发病后3个月,尤其是老年动脉瘤性蛛网膜下腔出血患者。
  • 本研究显示mWFNS量表可能比WFNS量表更准确地评估动脉瘤性蛛网膜下腔出血患者的结局。

研究设计与样本

  • 回顾性分析2010年1月至2012年12月mWFNS量表研究中前瞻性收集的接受治愈性治疗的动脉瘤性蛛网膜下腔出血患者数据。

主要发现

  • 出院至发病后3个月mRS评分改善者占28.3%,下降者占2.5%。
  • 入院WFNS和mWFNS Ⅱ-V级与发病后3个月mRS评分改善显著相关。
  • 年龄65-74岁 vs 年龄<65岁,比值比6.59,95%置信区间1.28-34.01;年龄≥75岁 vs 年龄<65岁,比值比17.67,95%置信区间2.11-148.26,均与发病后3个月mRS评分下降显著相关。
  • WFNS Ⅲ级与发病后3个月mRS评分下降显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study was to clarify the prevalence of and factors associated with changes in patients' outcomes between discharge and 3 months after the onset of aneurysmal subarachnoid hemorrhage (aSAH). Additionally, the World Federation of Neurosurgical Societies (WFNS) and modified WFNS (mWFNS) scales were compared. METHODS: The data of curatively treated patients with aSAH, collected prospectively in the mWFNS scale study between January 2010 and December 2012, were analyzed retrospectively. The improvement or decline in the modified Rankin Scale (mRS) scores between discharge and 3 months after onset was determined. A multivariable logistic regression analysis was performed to identify factors, such as age and WFNS and mWFNS grades, associated with changes in the outcome. RESULTS: The mRS scores improved in 28.3% and declined in 2.5% of the patients. WFNS and mWFNS grades Ⅱ-V on admission were significantly associated with improved mRS scores at 3 months after onset. Older age (age: 65-74 years vs. age <65 years, odds ratio: 6.59, 95% confidence interval: 1.28-34.01; age ≥75 years vs. age <65 years, odds ratio: 17.67, 95% confidence interval: 2.11-148.26) and WFNS grade III were significantly associated with a decline in mRS scores at 3 months after onset. CONCLUSIONS: The optimal timing for postdischarge assessment of outcomes may be at 3 months after onset, especially in older patients with aSAH. The mWFNS scale is presumed to more accurately assess the outcomes of patients with aSAH than the WFNS scale, as demonstrated in this study.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hosogai M, Ikawa F, Hidaka T, et al. Changes in Short-Term Outcomes After Discharge in Patients with Aneurysmal Subarachnoid Hemorrhage: A Multicenter, Prospective, Observational Study. World Neurosurg. 2022. PMID: 35688375. doi:10.1016/j.wneu.2022.05.140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。